CN106261200A - 葛根素和绞股蓝皂苷制备防三高饮品的工艺 - Google Patents
葛根素和绞股蓝皂苷制备防三高饮品的工艺 Download PDFInfo
- Publication number
- CN106261200A CN106261200A CN201510302587.6A CN201510302587A CN106261200A CN 106261200 A CN106261200 A CN 106261200A CN 201510302587 A CN201510302587 A CN 201510302587A CN 106261200 A CN106261200 A CN 106261200A
- Authority
- CN
- China
- Prior art keywords
- take
- puerarin
- standby
- gypenoside
- heated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 title claims abstract description 17
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 title claims abstract description 17
- 229930187479 gypenoside Natural products 0.000 title claims abstract description 13
- 238000000034 method Methods 0.000 title claims abstract description 13
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 title claims abstract description 12
- 235000013361 beverage Nutrition 0.000 title claims abstract description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000003756 stirring Methods 0.000 claims abstract description 14
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 10
- 235000003935 Hippophae Nutrition 0.000 claims abstract description 6
- 241000229143 Hippophae Species 0.000 claims abstract description 6
- 150000004676 glycans Chemical class 0.000 claims abstract description 6
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 6
- 239000005017 polysaccharide Substances 0.000 claims abstract description 6
- 239000000052 vinegar Substances 0.000 claims abstract description 6
- 235000021419 vinegar Nutrition 0.000 claims abstract description 6
- 108010011485 Aspartame Proteins 0.000 claims abstract description 5
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 claims abstract description 5
- 240000000249 Morus alba Species 0.000 claims abstract description 5
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 5
- 244000269722 Thea sinensis Species 0.000 claims abstract description 5
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims abstract description 5
- 229960003438 aspartame Drugs 0.000 claims abstract description 5
- 235000010357 aspartame Nutrition 0.000 claims abstract description 5
- 239000000605 aspartame Substances 0.000 claims abstract description 5
- 238000001816 cooling Methods 0.000 claims abstract description 5
- 229940109275 cyclamate Drugs 0.000 claims abstract description 5
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940093503 ethyl maltol Drugs 0.000 claims abstract description 5
- 239000012467 final product Substances 0.000 claims abstract description 5
- 239000011229 interlayer Substances 0.000 claims abstract description 5
- 238000007789 sealing Methods 0.000 claims abstract description 5
- 239000003381 stabilizer Substances 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- RWXIFXNRCLMQCD-JBVRGBGGSA-N (20S)-ginsenoside Rg3 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RWXIFXNRCLMQCD-JBVRGBGGSA-N 0.000 description 1
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical class O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 description 1
- 240000000972 Agathis dammara Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 229920002871 Dammar gum Polymers 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- XIRZPICFRDZXPF-UHFFFAOYSA-N Ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CC(O)C3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O XIRZPICFRDZXPF-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002224 folic acids Chemical class 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 201000004537 pyelitis Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明涉及的是一种葛根素和绞股蓝皂苷制备防三高饮品的工艺，其特征是：选用葛根素提取液、绞股蓝皂苷提取液、芹菜提取液与茶多糖、桑葚汁、沙棘汁进行充分混合后备用，再取纯净水500kg置于夹层配料罐内，对配料罐加热40℃时，加入前述的混合液搅拌均匀；再取阿斯巴甜、乙基麦芽酚、清甜素、柠檬酸、苹果醋、香精、护色素等，搅拌均匀，加温杀菌，罐装封口，冷却，包装即得。
Description
技术领域
本发明涉及的是一种葛根素和绞股蓝皂苷制备防三高饮品的工艺。
背景技术
三高人群越来越多，针对三高人群的保健品和药品也层出不穷，然而适合三高人群饮用的饮料，却少至又少。常常听到三高人群的呼声，能不能给我们研究一些日常可饮用的降三高饮料，让我们平时饮用，远离和减轻三高对我们的危害，不要让我们总是吃药。经过研究，结合中国人的饮食习惯，我们筛选了葛根素和绞股蓝皂苷当主料，研发成一种适合三高人群的，好喝的，有效防三高的饮料。
发明内容
本发明的目的是提供一种葛根素和绞股蓝皂苷制备防三高饮品的工艺。
本发明的目的是这样实现的：原料的制备和配比工艺：a、分别取葛根和绞股蓝单味采用超临界萃取工艺获取提取葛根素和绞股蓝皂苷备用；b、选用葛根素提取液45-50%、绞股蓝提取液25-30%、芹菜提取液20-30%，进行充分混合后备用；c、取茶多糖40%、桑葚汁20%、沙棘汁40%，进行充分混合后备用；d、取b步骤获得的混合液60%，c步骤获得的混合液40%，充分混合后，备用；e、制作：1、取纯净水500kg置于夹层配料罐内，通过锅炉加温，对配料罐加热40℃时，加入d步骤获得的混合液50%，搅拌均匀；2.取阿斯巴甜0.05kg，乙基麦芽酚0.05kg，清甜素0.10kg，溶解混合均匀，加入罐中，再取柠檬酸100ml，苹果醋380ml加入配料罐中，搅拌均匀后，再次加温至60℃时，加入香精50ml，护色素0.095kg，搅拌均匀，加温至85℃，进行杀菌，罐装封口，冷却，包装即得。
本发明的积极效果在于：葛根：有解肌退热，生津，透疹，升阳止泻的功能，用于外感发热头痛，项强，口渴，消渴，热痢，泄泻，高血压颈项强痛，冠心病等。其含葛根黄酮、葛根素，大豆异黄酮等，对梗死的心肌的代谢有良好作用。绞股蓝：味甘，苦，性平，有清热解毒，止咳祛痰，抗癌，防老，降血脂的功能，含有80多中皂苷，包括人参皂苷Rg3，氨基酸，23种无机元素，用于治疗慢性支气管炎、传染性肝炎、肾盂炎、肠胃炎、高血脂和降血糖、抗疲劳、抗肿瘤。80多种皂苷，均属于达玛脂醇类结构。其中6种绞股蓝皂苷：Rb1、Rb2、Rd、F1、Tn-1、Tn-2与人参皂苷相同，11种相似，是人参含量的3倍。芹菜：是一种常见的蔬菜，其维生素C含量很高，有减肥作用和降血脂、降血压作用。茶多糖：有很好的降血糖作用。桑葚：味甘、酸、性寒，用于补铁。铁是人体内最丰富的微量元素，主要以铁蛋白存在于体内。缺铁后血液蛋白减少，发生贫血、易疲劳、注意力不集中等症状。沙棘：活血化淤，消食，抗氧化，抗放射功效，含有大量的VC，是补充天然VC的重要原料，VC也是大脑中的重要物质之一，和钙结合能发挥出卓越健脑作用，并含大量黄酮类、叶酸类、葡萄糖、果糖等成份。
具体实施方式
实施例一：
原料的制备和配比工艺：a、分别取葛根和绞股蓝单味采用超临界萃取工艺获取提取葛根素和绞股蓝皂苷备用；b、选用葛根素提取液50%、绞股蓝提取液30%、芹菜提取液20%，进行充分混合后备用；c、取茶多糖40%、桑葚汁20%、沙棘汁40%，进行充分混合后备用；d、取b步骤获得的混合液60%，c步骤获得的混合液40%，充分混合后，备用；e、制作：1、取纯净水500kg置于夹层配料罐内，通过锅炉加温，对配料罐加热40℃时，加入d步骤获得的混合液50%，搅拌均匀；2.取阿斯巴甜0.05kg，乙基麦芽酚0.05kg，清甜素0.10kg，溶解混合均匀，加入罐中，再取柠檬酸100ml，苹果醋380ml加入配料罐中，搅拌均匀后，再次加温至60℃时，加入香精50ml，护色素0.095kg，搅拌均匀，加温至85℃，进行杀菌，罐装封口，冷却，包装即得。
实施例二：a、分别取葛根和绞股蓝单味采用超临界萃取工艺获取提取葛根素和绞股蓝皂苷备用；b、选用葛根素提取液45%绞股蓝提取液25%、芹菜提取液30%，进行充分混合后备用；c、取茶多糖40%、桑葚汁20%、沙棘汁40%，进行充分混合后备用；d、取b步骤获得的混合液60%，c步骤获得的混合液40%，充分混合后，备用；e、制作：1、取纯净水500kg置于夹层配料罐内，通过锅炉加温，对配料罐加热40℃时，加入d步骤获得的混合液50%，搅拌均匀；2.取阿斯巴甜0.05kg，乙基麦芽酚0.05kg，清甜素0.10kg，溶解混合均匀，加入罐中，再取柠檬酸100ml，苹果醋380ml加入配料罐中，搅拌均匀后，再次加温至60℃时，加入香精50ml，护色素0.095kg，搅拌均匀，加温至85℃，进行杀菌，罐装封口，冷却，包装即得。
通过实施例一或二所生产出的该果醋饮品，口感酸甜可口，营养丰富，适合三高人群和需要保健的人饮用。
Claims (1)
1.一种葛根素和绞股蓝皂苷制备防三高饮品的工艺，其特征是：由以下配比和方法制备而成：a、分别取葛根和绞股蓝单味采用超临界萃取工艺获取提取葛根素和绞股蓝皂苷备用；b、选用葛根素提取液45-50%、绞股蓝提取液25-30%、芹菜提取液20-30%，进行充分混合后备用；c、取茶多糖40%、桑葚汁20%、沙棘汁40%，进行充分混合后备用；d、取b步骤获得的混合液60%，c步骤获得的混合液40%，充分混合后，备用；e、制作：1、取纯净水500kg置于夹层配料罐内，通过锅炉加温，对配料罐加热40℃时，加入d步骤获得的混合液50%，搅拌均匀；2.取阿斯巴甜0.05kg，乙基麦芽酚0.05kg，清甜素0.10kg，溶解混合均匀，加入罐中，再取柠檬酸100ml，苹果醋380ml加入配料罐中，搅拌均匀后，再次加温至60℃时，加入香精50ml，护色素0.095kg，搅拌均匀，加温至85℃，进行杀菌，罐装封口，冷却，包装即得。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510302587.6A CN106261200A (zh) | 2015-06-04 | 2015-06-04 | 葛根素和绞股蓝皂苷制备防三高饮品的工艺 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510302587.6A CN106261200A (zh) | 2015-06-04 | 2015-06-04 | 葛根素和绞股蓝皂苷制备防三高饮品的工艺 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106261200A true CN106261200A (zh) | 2017-01-04 |
Family
ID=57655546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510302587.6A Pending CN106261200A (zh) | 2015-06-04 | 2015-06-04 | 葛根素和绞股蓝皂苷制备防三高饮品的工艺 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106261200A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107467433A (zh) * | 2017-09-01 | 2017-12-15 | 李东 | 一种降三高的功能性饮品及其制备方法 |
| CN108617821A (zh) * | 2017-03-22 | 2018-10-09 | 平利县绞股蓝研究所 | 一种含绞股蓝的防三高保健茶饮料及其制备方法 |
| CN109380633A (zh) * | 2018-11-15 | 2019-02-26 | 湖北华龙西科生物科技有限公司 | 一种生物纳米硒小分子水功能饮品及其制备方法 |
| CN113016973A (zh) * | 2021-02-03 | 2021-06-25 | 完美（广东）日用品有限公司 | 一种具有协同防治肿瘤功效的沙棘饮品其制备方法 |
-
2015
- 2015-06-04 CN CN201510302587.6A patent/CN106261200A/zh active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108617821A (zh) * | 2017-03-22 | 2018-10-09 | 平利县绞股蓝研究所 | 一种含绞股蓝的防三高保健茶饮料及其制备方法 |
| CN107467433A (zh) * | 2017-09-01 | 2017-12-15 | 李东 | 一种降三高的功能性饮品及其制备方法 |
| CN109380633A (zh) * | 2018-11-15 | 2019-02-26 | 湖北华龙西科生物科技有限公司 | 一种生物纳米硒小分子水功能饮品及其制备方法 |
| CN113016973A (zh) * | 2021-02-03 | 2021-06-25 | 完美（广东）日用品有限公司 | 一种具有协同防治肿瘤功效的沙棘饮品其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102871175B (zh) | 一种润肺止咳营养饮料及其制备方法 | |
| CN103689177B (zh) | 具有保健作用的中药咖啡饮品及其制备方法 | |
| CN104473249B (zh) | 一种松花粉的液体制剂及其制备方法 | |
| CN104351383A (zh) | 一种金银花刺梨复合速溶绿茶粉及其制备方法 | |
| CN101416736A (zh) | 一种营养滋补红枣酱及其制备方法 | |
| CN106174474A (zh) | 一种适用于心脑血管疾病患者食用的特膳食品 | |
| CN102885354A (zh) | 一种清热解暑营养饮料及其制备方法 | |
| CN105876548A (zh) | 一种玛咖人参果蔬饮料及其制备方法与应用 | |
| CN103859546B (zh) | 一种诺尼天然多功能复合饮料及其制备方法 | |
| CN106261200A (zh) | 葛根素和绞股蓝皂苷制备防三高饮品的工艺 | |
| CN104207241B (zh) | 一种药食同源复合保健饮料及其制备方法 | |
| CN102551139A (zh) | 红枣黄芪减肥浓浆 | |
| CN101803657B (zh) | 一种橄榄原味果茶的制备方法 | |
| CN106106917A (zh) | 紫五加酵素茶及其制备方法 | |
| CN103734767B (zh) | 一种保健食品 | |
| CN103103098A (zh) | 一种果汁型保健黄酒饮料及生产方法 | |
| CN101253986B (zh) | 多功能营养复合保健饮料及其制备方法 | |
| CN110200182A (zh) | 一种具聪耳明目功能的植物发酵饮料及其制备方法 | |
| CN104544405A (zh) | 一种荔枝味改善宇航员睡眠质量功能饮料及其制备方法 | |
| CN106901082A (zh) | 沙棘甲壳素防三高饮料 | |
| CN106261204A (zh) | 用黄秋葵和玉米须制作降血压果醋饮料的方法 | |
| CN109430654A (zh) | 一种什锦果蔬中草药生物活性复合菌功能性饮料及其制备方法 | |
| CN104789401A (zh) | 一种西洋参红葡萄酒的制备方法 | |
| CN104642607A (zh) | 低糖银杏茶饮料及其制备方法 | |
| CN104770736A (zh) | 一种西洋红参口服液的制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170104 |
|
| WD01 | Invention patent application deemed withdrawn after publication |